ALHC

NEW YORK, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces an investigation into Alignment Healthcare, Inc. (NASDAQ:ALHC) for potential securities fraud after its significant stock drop. If you invested in Alignment securities, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/alignment-class-action-lawsuit.

BFA Law is investigating whether Alignment Healthcare, Inc. committed securities fraud relating to allegations that the company and its senior executives artificially inflated adjusted EBITDA to boost executive compensation. NEW YORK, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces an investigation into Alignment Healthcare, Inc. (NASDAQ:ALHC) for potential securities fraud after its significant stock drop.

BFA Law is investigating whether Alignment Healthcare, Inc. committed securities fraud relating to allegations that the company and its senior executives artificially inflated adjusted EBITDA to boost executive compensation. NEW YORK, Nov. 3, 2026 /PRNewswire/ -- Leading securities law firm Bleichmar Fonti & Auld LLP  announces an investigation into Alignment Healthcare, Inc. (NASDAQ: ALHC) for potential securities fraud after its significant stock drop.

NEW YORK--(BUSINESS WIRE)---- $ALHC #ALHC--Alignment Healthcare Investors are Notified to Contact BFA Law About the Ongoing Securities Fraud Investigation.

SAN FRANCISCO, Oct. 30, 2026 /PRNewswire/ -- On October 9, 2026, investors Alignment Healthcare, Inc. (NASDAQ: ALHC) saw the price of their shares slide another 13% to close at $7.55, reaching a 52 week low, after the Centers for Medicare & Medicaid Services ("CMS") lowered its 2027 4.0 Star Rating to a 3.5 Star Rating for Alignment's California HMO health plan contract ("H3815"), which serves 75% of Alignment's health plan membership. The revelations follow growing investor concerns over H3815's performance during CMS' measurement period, including "cut points" established by CMS to assess H3815's Star Rating.

Investigation follows the July 8, 2026 disclosure regarding Alignment Healthcare, Inc.; investors who lost money may have claims to recover their losses Investigation follows the July 8, 2026 disclosure regarding Alignment Healthcare, Inc.; investors who lost money may have claims to recover their losses

Boston, Massachusetts--(Newsfile Corp. - October 30, 2026) - Block & Leviton is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for potential securities law violations. Investors who have lost money in their Alignment Healthcare, Inc. investment should contact the firm to learn more about how they might recover those losses.

NEW YORK, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm  Bleichmar Fonti & Auld LLP announces an investigation into Alignment Healthcare, Inc. (NASDAQ:ALHC) for potential securities fraud after its significant stock drop. If you invested in Alignment securities, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/alignment-class-action-lawsuit.

Alignment Healthcare, Inc. (ALHC) Q3 2026 Earnings Call Transcript

ORANGE, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today reported financial results for its third quarter ended Sept. 30, 2026.